Elsevier's ClinicalPath Earns ASCO Certification for Oncology Care Standards
Event summary
- Elsevier's ClinicalPath received Recognized Quality Solution (RQS) designation from ASCO on May 6, 2026.
- The certification validates ClinicalPath's alignment with ASCO Certified standards for oncology care.
- ClinicalPath underwent rigorous validation for clinical quality measurement and pathway utilization.
- The designation supports cancer practices in quality reporting and compliance with value-based care models.
The big picture
Elsevier's ClinicalPath certification underscores the growing emphasis on standardized, evidence-based oncology care. The ASCO Certified program's rigorous standards aim to unify cancer care delivery, aligning with broader industry shifts toward value-based care and quality measurement. This designation positions ClinicalPath as a key player in helping cancer practices navigate regulatory and reporting requirements, potentially expanding its market reach within the oncology sector.
What we're watching
- Adoption Pace
- How quickly cancer centers will integrate ClinicalPath to meet ASCO Certified standards.
- Competitive Response
- Whether competitors will seek similar certifications to remain relevant in oncology decision support.
- Value-Based Care
- The extent to which ClinicalPath's support for value-based care models will influence payer negotiations.
Related topics